nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—Etoposide—sarcoma	0.187	0.542	CbGbCtD
Diflunisal—PTGS1—Etoposide—sarcoma	0.158	0.458	CbGbCtD
Diflunisal—PTGS2—periosteum—sarcoma	0.0156	0.0801	CbGeAlD
Diflunisal—PTGS2—leg—sarcoma	0.0124	0.0638	CbGeAlD
Diflunisal—PTGS2—hindlimb—sarcoma	0.0111	0.057	CbGeAlD
Diflunisal—PTGS2—cartilage tissue—sarcoma	0.0109	0.0561	CbGeAlD
Diflunisal—PTGS2—appendage—sarcoma	0.00952	0.0489	CbGeAlD
Diflunisal—UGT1A8—liver—sarcoma	0.00916	0.047	CbGeAlD
Diflunisal—TTR—embryo—sarcoma	0.00909	0.0467	CbGeAlD
Diflunisal—ALB—mammary gland—sarcoma	0.0085	0.0437	CbGeAlD
Diflunisal—TTR—hematopoietic system—sarcoma	0.00812	0.0417	CbGeAlD
Diflunisal—TTR—connective tissue—sarcoma	0.00782	0.0401	CbGeAlD
Diflunisal—PTGS1—endothelium—sarcoma	0.00601	0.0309	CbGeAlD
Diflunisal—PTGS2—endothelium—sarcoma	0.00575	0.0295	CbGeAlD
Diflunisal—TTR—lymphoid tissue—sarcoma	0.00572	0.0294	CbGeAlD
Diflunisal—TTR—bone marrow—sarcoma	0.0052	0.0267	CbGeAlD
Diflunisal—TTR—testis—sarcoma	0.00445	0.0228	CbGeAlD
Diflunisal—TTR—liver—sarcoma	0.00421	0.0216	CbGeAlD
Diflunisal—PTGS2—myometrium—sarcoma	0.00329	0.0169	CbGeAlD
Diflunisal—PTGS2—embryo—sarcoma	0.00316	0.0162	CbGeAlD
Diflunisal—PTGS1—seminal vesicle—sarcoma	0.00311	0.016	CbGeAlD
Diflunisal—PTGS2—seminal vesicle—sarcoma	0.00297	0.0153	CbGeAlD
Diflunisal—PTGS1—hematopoietic system—sarcoma	0.00295	0.0152	CbGeAlD
Diflunisal—PTGS1—connective tissue—sarcoma	0.00284	0.0146	CbGeAlD
Diflunisal—ALB—testis—sarcoma	0.00284	0.0146	CbGeAlD
Diflunisal—PTGS2—hematopoietic system—sarcoma	0.00282	0.0145	CbGeAlD
Diflunisal—PTGS2—connective tissue—sarcoma	0.00272	0.014	CbGeAlD
Diflunisal—Agranulocytosis—Mitoxantrone—sarcoma	0.00269	0.00585	CcSEcCtD
Diflunisal—ALB—liver—sarcoma	0.00268	0.0138	CbGeAlD
Diflunisal—Bronchospasm—Etoposide—sarcoma	0.00265	0.00575	CcSEcCtD
Diflunisal—Hallucination—Vincristine—sarcoma	0.00264	0.00575	CcSEcCtD
Diflunisal—PTGS1—smooth muscle tissue—sarcoma	0.0026	0.0134	CbGeAlD
Diflunisal—Hepatitis—Mitoxantrone—sarcoma	0.00259	0.00563	CcSEcCtD
Diflunisal—PTGS1—skin of body—sarcoma	0.00257	0.0132	CbGeAlD
Diflunisal—Tension—Thiotepa—sarcoma	0.00256	0.00557	CcSEcCtD
Diflunisal—Nervousness—Thiotepa—sarcoma	0.00253	0.00551	CcSEcCtD
Diflunisal—PTGS2—smooth muscle tissue—sarcoma	0.00249	0.0128	CbGeAlD
Diflunisal—Vision blurred—Thiotepa—sarcoma	0.00246	0.00535	CcSEcCtD
Diflunisal—PTGS2—skin of body—sarcoma	0.00245	0.0126	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00238	0.00517	CcSEcCtD
Diflunisal—Eructation—Epirubicin—sarcoma	0.00236	0.00514	CcSEcCtD
Diflunisal—Renal failure—Etoposide—sarcoma	0.00236	0.00513	CcSEcCtD
Diflunisal—Jaundice—Etoposide—sarcoma	0.00234	0.00508	CcSEcCtD
Diflunisal—Stomatitis—Etoposide—sarcoma	0.00234	0.00508	CcSEcCtD
Diflunisal—PTGS1—cardiac atrium—sarcoma	0.00224	0.0115	CbGeAlD
Diflunisal—Agranulocytosis—Etoposide—sarcoma	0.00224	0.00487	CcSEcCtD
Diflunisal—PTGS1—uterus—sarcoma	0.00223	0.0115	CbGeAlD
Diflunisal—Eructation—Doxorubicin—sarcoma	0.00218	0.00475	CcSEcCtD
Diflunisal—Confusional state—Thiotepa—sarcoma	0.00215	0.00467	CcSEcCtD
Diflunisal—PTGS2—uterus—sarcoma	0.00213	0.0109	CbGeAlD
Diflunisal—Vision blurred—Mitoxantrone—sarcoma	0.00212	0.00462	CcSEcCtD
Diflunisal—Oedema—Dactinomycin—sarcoma	0.00211	0.0046	CcSEcCtD
Diflunisal—Thrombocytopenia—Thiotepa—sarcoma	0.00209	0.00453	CcSEcCtD
Diflunisal—Vertigo—Vincristine—sarcoma	0.00208	0.00452	CcSEcCtD
Diflunisal—Thrombocytopenia—Dactinomycin—sarcoma	0.00207	0.0045	CcSEcCtD
Diflunisal—ALB—lymph node—sarcoma	0.00206	0.0106	CbGeAlD
Diflunisal—Erythema multiforme—Etoposide—sarcoma	0.00204	0.00443	CcSEcCtD
Diflunisal—Anorexia—Thiotepa—sarcoma	0.00203	0.00441	CcSEcCtD
Diflunisal—Anorexia—Dactinomycin—sarcoma	0.00201	0.00438	CcSEcCtD
Diflunisal—Flushing—Etoposide—sarcoma	0.002	0.00435	CcSEcCtD
Diflunisal—PTGS2—lymphoid tissue—sarcoma	0.00199	0.0102	CbGeAlD
Diflunisal—Photosensitivity—Epirubicin—sarcoma	0.00199	0.00432	CcSEcCtD
Diflunisal—PTGS1—tendon—sarcoma	0.00195	0.01	CbGeAlD
Diflunisal—Chest pain—Mitoxantrone—sarcoma	0.00192	0.00417	CcSEcCtD
Diflunisal—Paraesthesia—Thiotepa—sarcoma	0.00191	0.00416	CcSEcCtD
Diflunisal—Somnolence—Thiotepa—sarcoma	0.00189	0.00412	CcSEcCtD
Diflunisal—Anaphylactic shock—Vincristine—sarcoma	0.00189	0.00411	CcSEcCtD
Diflunisal—Oedema—Vincristine—sarcoma	0.00189	0.00411	CcSEcCtD
Diflunisal—Dyspepsia—Thiotepa—sarcoma	0.00187	0.00408	CcSEcCtD
Diflunisal—PTGS2—tendon—sarcoma	0.00187	0.00959	CbGeAlD
Diflunisal—Confusional state—Mitoxantrone—sarcoma	0.00185	0.00403	CcSEcCtD
Diflunisal—Decreased appetite—Thiotepa—sarcoma	0.00185	0.00403	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Epirubicin—sarcoma	0.00185	0.00402	CcSEcCtD
Diflunisal—Thrombocytopenia—Vincristine—sarcoma	0.00185	0.00402	CcSEcCtD
Diflunisal—Anaphylactic shock—Mitoxantrone—sarcoma	0.00184	0.004	CcSEcCtD
Diflunisal—Oedema—Mitoxantrone—sarcoma	0.00184	0.004	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—sarcoma	0.00184	0.004	CcSEcCtD
Diflunisal—Decreased appetite—Dactinomycin—sarcoma	0.00184	0.004	CcSEcCtD
Diflunisal—Fatigue—Thiotepa—sarcoma	0.00184	0.00399	CcSEcCtD
Diflunisal—Renal impairment—Epirubicin—sarcoma	0.00183	0.00399	CcSEcCtD
Diflunisal—Hyperhidrosis—Vincristine—sarcoma	0.00183	0.00397	CcSEcCtD
Diflunisal—Fatigue—Dactinomycin—sarcoma	0.00182	0.00396	CcSEcCtD
Diflunisal—Constipation—Thiotepa—sarcoma	0.00182	0.00396	CcSEcCtD
Diflunisal—PTGS2—bone marrow—sarcoma	0.00181	0.00929	CbGeAlD
Diflunisal—Shock—Mitoxantrone—sarcoma	0.00181	0.00394	CcSEcCtD
Diflunisal—Muscle spasms—Etoposide—sarcoma	0.0018	0.00392	CcSEcCtD
Diflunisal—Thrombocytopenia—Mitoxantrone—sarcoma	0.0018	0.00392	CcSEcCtD
Diflunisal—Anorexia—Vincristine—sarcoma	0.0018	0.00391	CcSEcCtD
Diflunisal—Hyperhidrosis—Mitoxantrone—sarcoma	0.00178	0.00387	CcSEcCtD
Diflunisal—Feeling abnormal—Thiotepa—sarcoma	0.00175	0.00382	CcSEcCtD
Diflunisal—Anorexia—Mitoxantrone—sarcoma	0.00175	0.00381	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00174	0.00379	CcSEcCtD
Diflunisal—Feeling abnormal—Dactinomycin—sarcoma	0.00174	0.00379	CcSEcCtD
Diflunisal—Gastrointestinal pain—Thiotepa—sarcoma	0.00174	0.00379	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dactinomycin—sarcoma	0.00173	0.00376	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00171	0.00372	CcSEcCtD
Diflunisal—Insomnia—Vincristine—sarcoma	0.00171	0.00371	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—sarcoma	0.0017	0.00369	CcSEcCtD
Diflunisal—Paraesthesia—Vincristine—sarcoma	0.0017	0.00369	CcSEcCtD
Diflunisal—Urticaria—Thiotepa—sarcoma	0.00169	0.00368	CcSEcCtD
Diflunisal—Vertigo—Etoposide—sarcoma	0.00168	0.00366	CcSEcCtD
Diflunisal—Body temperature increased—Thiotepa—sarcoma	0.00168	0.00366	CcSEcCtD
Diflunisal—Body temperature increased—Dactinomycin—sarcoma	0.00167	0.00363	CcSEcCtD
Diflunisal—Paraesthesia—Mitoxantrone—sarcoma	0.00165	0.00359	CcSEcCtD
Diflunisal—Loss of consciousness—Etoposide—sarcoma	0.00165	0.00358	CcSEcCtD
Diflunisal—Decreased appetite—Vincristine—sarcoma	0.00164	0.00357	CcSEcCtD
Diflunisal—Dyspnoea—Mitoxantrone—sarcoma	0.00164	0.00357	CcSEcCtD
Diflunisal—Somnolence—Mitoxantrone—sarcoma	0.00163	0.00356	CcSEcCtD
Diflunisal—Fatigue—Vincristine—sarcoma	0.00163	0.00354	CcSEcCtD
Diflunisal—Dyspepsia—Mitoxantrone—sarcoma	0.00162	0.00352	CcSEcCtD
Diflunisal—PTGS1—testis—sarcoma	0.00162	0.00831	CbGeAlD
Diflunisal—Constipation—Vincristine—sarcoma	0.00161	0.00351	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00161	0.00351	CcSEcCtD
Diflunisal—Decreased appetite—Mitoxantrone—sarcoma	0.0016	0.00348	CcSEcCtD
Diflunisal—Chest pain—Etoposide—sarcoma	0.0016	0.00347	CcSEcCtD
Diflunisal—Fatigue—Mitoxantrone—sarcoma	0.00159	0.00345	CcSEcCtD
Diflunisal—Constipation—Mitoxantrone—sarcoma	0.00157	0.00342	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00157	0.00342	CcSEcCtD
Diflunisal—Hypersensitivity—Thiotepa—sarcoma	0.00157	0.00341	CcSEcCtD
Diflunisal—Hypersensitivity—Dactinomycin—sarcoma	0.00156	0.00339	CcSEcCtD
Diflunisal—Gastrointestinal pain—Vincristine—sarcoma	0.00154	0.00336	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—sarcoma	0.00154	0.00336	CcSEcCtD
Diflunisal—Confusional state—Etoposide—sarcoma	0.00154	0.00335	CcSEcCtD
Diflunisal—Anaphylactic shock—Etoposide—sarcoma	0.00153	0.00333	CcSEcCtD
Diflunisal—Asthenia—Thiotepa—sarcoma	0.00153	0.00332	CcSEcCtD
Diflunisal—Asthenia—Dactinomycin—sarcoma	0.00152	0.0033	CcSEcCtD
Diflunisal—Feeling abnormal—Mitoxantrone—sarcoma	0.00152	0.0033	CcSEcCtD
Diflunisal—Pruritus—Thiotepa—sarcoma	0.00151	0.00328	CcSEcCtD
Diflunisal—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0015	0.00327	CcSEcCtD
Diflunisal—Thrombocytopenia—Etoposide—sarcoma	0.0015	0.00326	CcSEcCtD
Diflunisal—Body temperature increased—Vincristine—sarcoma	0.00149	0.00325	CcSEcCtD
Diflunisal—Hyperhidrosis—Etoposide—sarcoma	0.00148	0.00322	CcSEcCtD
Diflunisal—PTGS2—liver—sarcoma	0.00146	0.00751	CbGeAlD
Diflunisal—Urticaria—Mitoxantrone—sarcoma	0.00146	0.00318	CcSEcCtD
Diflunisal—Anorexia—Etoposide—sarcoma	0.00146	0.00317	CcSEcCtD
Diflunisal—Diarrhoea—Thiotepa—sarcoma	0.00146	0.00317	CcSEcCtD
Diflunisal—Body temperature increased—Mitoxantrone—sarcoma	0.00145	0.00316	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00145	0.00316	CcSEcCtD
Diflunisal—Diarrhoea—Dactinomycin—sarcoma	0.00145	0.00315	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—sarcoma	0.00143	0.00311	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—sarcoma	0.00141	0.00307	CcSEcCtD
Diflunisal—Dizziness—Thiotepa—sarcoma	0.00141	0.00306	CcSEcCtD
Diflunisal—Hypersensitivity—Vincristine—sarcoma	0.00139	0.00303	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—sarcoma	0.00138	0.00299	CcSEcCtD
Diflunisal—Paraesthesia—Etoposide—sarcoma	0.00137	0.00299	CcSEcCtD
Diflunisal—Dyspnoea—Etoposide—sarcoma	0.00136	0.00297	CcSEcCtD
Diflunisal—Somnolence—Etoposide—sarcoma	0.00136	0.00296	CcSEcCtD
Diflunisal—Hypersensitivity—Mitoxantrone—sarcoma	0.00135	0.00295	CcSEcCtD
Diflunisal—Asthenia—Vincristine—sarcoma	0.00135	0.00295	CcSEcCtD
Diflunisal—Vomiting—Thiotepa—sarcoma	0.00135	0.00294	CcSEcCtD
Diflunisal—Vomiting—Dactinomycin—sarcoma	0.00134	0.00292	CcSEcCtD
Diflunisal—Rash—Thiotepa—sarcoma	0.00134	0.00292	CcSEcCtD
Diflunisal—Dermatitis—Thiotepa—sarcoma	0.00134	0.00292	CcSEcCtD
Diflunisal—Headache—Thiotepa—sarcoma	0.00133	0.0029	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00133	0.0029	CcSEcCtD
Diflunisal—Rash—Dactinomycin—sarcoma	0.00133	0.0029	CcSEcCtD
Diflunisal—Decreased appetite—Etoposide—sarcoma	0.00133	0.00289	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—sarcoma	0.00132	0.00287	CcSEcCtD
Diflunisal—Asthenia—Mitoxantrone—sarcoma	0.00132	0.00287	CcSEcCtD
Diflunisal—Fatigue—Etoposide—sarcoma	0.00132	0.00287	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—sarcoma	0.00131	0.00285	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—sarcoma	0.00131	0.00285	CcSEcCtD
Diflunisal—Constipation—Etoposide—sarcoma	0.00131	0.00285	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—sarcoma	0.0013	0.00284	CcSEcCtD
Diflunisal—Diarrhoea—Vincristine—sarcoma	0.00129	0.00281	CcSEcCtD
Diflunisal—Sweating—Epirubicin—sarcoma	0.00129	0.0028	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—sarcoma	0.00128	0.00279	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—sarcoma	0.00127	0.00277	CcSEcCtD
Diflunisal—Nausea—Thiotepa—sarcoma	0.00126	0.00275	CcSEcCtD
Diflunisal—Feeling abnormal—Etoposide—sarcoma	0.00126	0.00274	CcSEcCtD
Diflunisal—Diarrhoea—Mitoxantrone—sarcoma	0.00126	0.00274	CcSEcCtD
Diflunisal—Nausea—Dactinomycin—sarcoma	0.00126	0.00273	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—sarcoma	0.00125	0.00273	CcSEcCtD
Diflunisal—Gastrointestinal pain—Etoposide—sarcoma	0.00125	0.00272	CcSEcCtD
Diflunisal—Dizziness—Vincristine—sarcoma	0.00125	0.00272	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00123	0.00268	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—sarcoma	0.00122	0.00266	CcSEcCtD
Diflunisal—Urticaria—Etoposide—sarcoma	0.00122	0.00264	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—sarcoma	0.00121	0.00264	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—sarcoma	0.00121	0.00264	CcSEcCtD
Diflunisal—Body temperature increased—Etoposide—sarcoma	0.00121	0.00263	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—sarcoma	0.00121	0.00262	CcSEcCtD
Diflunisal—Vomiting—Vincristine—sarcoma	0.0012	0.00261	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—sarcoma	0.00119	0.00259	CcSEcCtD
Diflunisal—Rash—Vincristine—sarcoma	0.00119	0.00259	CcSEcCtD
Diflunisal—Dermatitis—Vincristine—sarcoma	0.00119	0.00259	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—sarcoma	0.00119	0.00258	CcSEcCtD
Diflunisal—Headache—Vincristine—sarcoma	0.00118	0.00257	CcSEcCtD
Diflunisal—PTGS1—lymph node—sarcoma	0.00117	0.00602	CbGeAlD
Diflunisal—Vomiting—Mitoxantrone—sarcoma	0.00117	0.00254	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—sarcoma	0.00116	0.00253	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—sarcoma	0.00116	0.00252	CcSEcCtD
Diflunisal—Rash—Mitoxantrone—sarcoma	0.00116	0.00252	CcSEcCtD
Diflunisal—Dermatitis—Mitoxantrone—sarcoma	0.00116	0.00252	CcSEcCtD
Diflunisal—Headache—Mitoxantrone—sarcoma	0.00115	0.00251	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—sarcoma	0.00114	0.00248	CcSEcCtD
Diflunisal—Hypersensitivity—Etoposide—sarcoma	0.00113	0.00245	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—sarcoma	0.00113	0.00245	CcSEcCtD
Diflunisal—Nausea—Vincristine—sarcoma	0.00112	0.00244	CcSEcCtD
Diflunisal—PTGS2—lymph node—sarcoma	0.00112	0.00576	CbGeAlD
Diflunisal—Flushing—Epirubicin—sarcoma	0.00112	0.00244	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—sarcoma	0.00112	0.00243	CcSEcCtD
Diflunisal—Asthenia—Etoposide—sarcoma	0.0011	0.00239	CcSEcCtD
Diflunisal—Nausea—Mitoxantrone—sarcoma	0.00109	0.00238	CcSEcCtD
Diflunisal—Pruritus—Etoposide—sarcoma	0.00108	0.00235	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—sarcoma	0.00108	0.00234	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—sarcoma	0.00106	0.0023	CcSEcCtD
Diflunisal—Diarrhoea—Etoposide—sarcoma	0.00105	0.00228	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—sarcoma	0.00104	0.00226	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—sarcoma	0.00104	0.00225	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—sarcoma	0.00104	0.00225	CcSEcCtD
Diflunisal—Tension—Epirubicin—sarcoma	0.00103	0.00224	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—sarcoma	0.00102	0.00222	CcSEcCtD
Diflunisal—Dizziness—Etoposide—sarcoma	0.00101	0.0022	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—sarcoma	0.00101	0.0022	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—sarcoma	0.00099	0.00215	CcSEcCtD
Diflunisal—Vomiting—Etoposide—sarcoma	0.000973	0.00212	CcSEcCtD
Diflunisal—Rash—Etoposide—sarcoma	0.000964	0.0021	CcSEcCtD
Diflunisal—Dermatitis—Etoposide—sarcoma	0.000964	0.0021	CcSEcCtD
Diflunisal—Headache—Etoposide—sarcoma	0.000958	0.00208	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—sarcoma	0.000958	0.00208	CcSEcCtD
Diflunisal—Tension—Doxorubicin—sarcoma	0.000954	0.00207	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—sarcoma	0.000944	0.00205	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—sarcoma	0.000944	0.00205	CcSEcCtD
Diflunisal—Syncope—Epirubicin—sarcoma	0.000942	0.00205	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—sarcoma	0.000935	0.00203	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—sarcoma	0.000928	0.00202	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—sarcoma	0.000923	0.00201	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—sarcoma	0.000916	0.00199	CcSEcCtD
Diflunisal—Nausea—Etoposide—sarcoma	0.000909	0.00198	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—sarcoma	0.000894	0.00195	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—sarcoma	0.000873	0.0019	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—sarcoma	0.000872	0.0019	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—sarcoma	0.000865	0.00188	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—sarcoma	0.000859	0.00187	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—sarcoma	0.000857	0.00186	CcSEcCtD
Diflunisal—Oedema—Epirubicin—sarcoma	0.000857	0.00186	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—sarcoma	0.000854	0.00186	CcSEcCtD
Diflunisal—Shock—Epirubicin—sarcoma	0.000844	0.00183	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—sarcoma	0.00084	0.00183	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—sarcoma	0.000829	0.0018	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—sarcoma	0.000828	0.0018	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—sarcoma	0.000817	0.00178	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—sarcoma	0.0008	0.00174	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—sarcoma	0.000793	0.00173	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—sarcoma	0.000793	0.00173	CcSEcCtD
Diflunisal—Shock—Doxorubicin—sarcoma	0.000781	0.0017	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—sarcoma	0.000777	0.00169	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—sarcoma	0.000776	0.00169	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—sarcoma	0.00077	0.00167	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—sarcoma	0.000767	0.00167	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—sarcoma	0.000764	0.00166	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—sarcoma	0.000762	0.00166	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—sarcoma	0.000756	0.00164	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—sarcoma	0.000755	0.00164	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—sarcoma	0.000745	0.00162	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—sarcoma	0.000739	0.00161	CcSEcCtD
Diflunisal—Constipation—Epirubicin—sarcoma	0.000733	0.00159	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—sarcoma	0.000718	0.00156	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—sarcoma	0.000712	0.00155	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—sarcoma	0.000707	0.00154	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—sarcoma	0.000707	0.00154	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—sarcoma	0.000705	0.00153	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—sarcoma	0.000701	0.00153	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—sarcoma	0.000698	0.00152	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—sarcoma	0.00069	0.0015	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—sarcoma	0.000684	0.00149	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—sarcoma	0.000681	0.00148	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—sarcoma	0.000678	0.00148	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—sarcoma	0.000678	0.00147	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—sarcoma	0.000654	0.00142	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—sarcoma	0.000649	0.00141	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—sarcoma	0.000632	0.00137	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—sarcoma	0.00063	0.00137	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—sarcoma	0.000627	0.00136	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—sarcoma	0.000615	0.00134	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—sarcoma	0.000607	0.00132	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—sarcoma	0.000587	0.00128	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—sarcoma	0.000585	0.00127	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—sarcoma	0.000569	0.00124	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—sarcoma	0.000567	0.00123	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—sarcoma	0.000561	0.00122	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—sarcoma	0.000545	0.00119	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—sarcoma	0.000543	0.00118	CcSEcCtD
Diflunisal—Rash—Epirubicin—sarcoma	0.000541	0.00118	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—sarcoma	0.00054	0.00117	CcSEcCtD
Diflunisal—Headache—Epirubicin—sarcoma	0.000537	0.00117	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—sarcoma	0.000525	0.00114	CcSEcCtD
Diflunisal—Nausea—Epirubicin—sarcoma	0.000509	0.00111	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—sarcoma	0.000504	0.0011	CcSEcCtD
Diflunisal—Rash—Doxorubicin—sarcoma	0.0005	0.00109	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—sarcoma	0.0005	0.00109	CcSEcCtD
Diflunisal—Headache—Doxorubicin—sarcoma	0.000497	0.00108	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—sarcoma	0.000471	0.00102	CcSEcCtD
